Investment
Features
FeesSafety
Academy
More
Pluang+

Ondas shares drop 5% despite $165M new orders amid sector-wide drone stock selloff

Market News
07 Oct 2026
24/7 Wall Street
View Source
Bearish
Ondas shares drop 5% despite $165M new orders amid sector-wide drone stock selloff

Ondas announced over $165 million in new orders, expanding its backlog and revenue visibility, yet its stock fell 5%, mirroring declines in drone rivals AeroVironment and Red Cat. The selloff reflects broader sector pressure rather than company-specific issues, as investors await revenue conversion from Ondas' growing order book. Key programs ULTRA and IonStrike are advancing, but market reaction remains cautious. Investors should watch how quickly Ondas converts orders to revenue and monitor the Defiance Drone ETF for signs of sector stabilization.

Ondas' recent order announcement provides context for the Industrials sector's performance on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Oct 07, 2026 23:01 WIB: of 93 priced Industrials-sector US stocks, 13 rose and 79 fell. Notable movers include CNM at USD 39.62 down 5.89%, AGCO at USD 109.37 down 5.87%, and Planet Labs at USD 17.52 down 5.65% with a typical hold time of 3 days and Pluang order activity showing 57% Sell versus 43% Buy.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
2 hours ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
2 hours ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
3 hours ago
Forensic report urges LAPTOP token market makers to buy back and burn tokens after volatile launch.

Forensic report urges LAPTOP token market makers to buy back and burn tokens after volatile launch.

A forensic report on the LAPTOP token's launch revealed a sharp price rise and fall within the first hour of trading, linked to market-maker activity. The report calls on market makers involved to repurchase and burn tokens to stabilize the market. P...

Market News
Bearish
4 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App